mhurhangee/ep-ind-claims huggingface dataset:
A method for directing acquired image data to a host computer installed at or near a dental treatment site in an environment comprising multiple wireless access points (30a, 30b), wherein the host computer comprises a receiving address and is configured to store image data in a computer-accessible electronic memory, and wherein the dental treatment site is associated with a specific one of the multiple wireless access points and comprises: - a digital sensor, - a sensor controller associated with the digital sensor, - a wireless communication device provided in or associated with the controller, and - a radio-frequency identification device, programmed to communicate with any nearby controller to provide assignment information so that the acquired image data is directed to the host computer, the method comprising the steps of: - positioning the sensor controller near the programmed radio-frequency identification device at the dental treatment site; - providing a command that configures the sensor controller to encode and transmit image data content for delivery to the receiving address of the host computer according to the assignment information which is obtained, by means of the wireless communication device, from the programmed radio-frequency identification device; - positioning the digital sensor in proximity to a subject; - acquiring image data from the digital sensor; - wirelessly transmitting the acquired image data from the sensor controller to the wireless access point; - transmitting the acquired image data from the wireless access point to the host computer at the receiving address; and - storing the acquired transmitted image data in the computer-accessible electronic memory. - a digital sensor, - a sensor controller associated with the digital sensor, - a wireless communication device provided in or associated with the controller, and - a radio-frequency identification device, programmed to communicate with any nearby controller to provide assignment information so that the acquired image data is directed to the host computer, - positioning the sensor controller near the programmed radio-frequency identification device at the dental treatment site; - providing a command that configures the sensor controller to encode and transmit image data content for delivery to the receiving address of the host computer according to the assignment information which is obtained, by means of the wireless communication device, from the programmed radio-frequency identification device; - positioning the digital sensor in proximity to a subject; - acquiring image data from the digital sensor; - wirelessly transmitting the acquired image data from the sensor controller to the wireless access point; - transmitting the acquired image data from the wireless access point to the host computer at the receiving address; and - storing the acquired transmitted image data in the computer-accessible electronic memory.
A method for measuring the specific absorption rate SAR of a mobile device under test enabled for a combined LTE RF and 5G RF transmission, the method comprising the following steps: a.) Providing a mobile device under test operable in LTE RF and 5G standard, b.) Setting the DUT in a mode to transmit with maximum power level according to the 5G standard, and at the same time transmitting with lower power level of LTE RF standard, wherein the DUT is made to establish a link in 5G standard with a communication tester base station, wherein all data transfer is conducted in 5G standard, and all non-data transfer, such as signaling and synchronization, is conducted in LTE RF standard, c.) Performing a SAR scan to measure the SAR of the 5G signal, neglecting any contribution from the LTE RF signal, d.) Setting the in a mode to transmit with maximum power at maximum power in LTE RF standard, without transmitting according to the 5G standard, e.) Performing a SAR scan to measure the SAR of the LTE RF standard signal, f.) Combining the SAR results of step c.) and e.) thus obtaining a combined SAR value. a.) Providing a mobile device under test operable in LTE RF and 5G standard, b.) Setting the DUT in a mode to transmit with maximum power level according to the 5G standard, and at the same time transmitting with lower power level of LTE RF standard, wherein the DUT is made to establish a link in 5G standard with a communication tester base station, wherein all data transfer is conducted in 5G standard, and all non-data transfer, such as signaling and synchronization, is conducted in LTE RF standard, c.) Performing a SAR scan to measure the SAR of the 5G signal, neglecting any contribution from the LTE RF signal, d.) Setting the in a mode to transmit with maximum power at maximum power in LTE RF standard, without transmitting according to the 5G standard, e.) Performing a SAR scan to measure the SAR of the LTE RF standard signal, f.) Combining the SAR results of step c.) and e.) thus obtaining a combined SAR value.
Use of at least one substance stimulating the expression of a receptor of a neuromediator coded by the POMC gene chosen from among MC-1R, MC-2R, and μ opioid R, in at least one type of skin cells expressing at least one of these receptors and a product of the POMC gene, as an active ingredient in a cosmetic composition, wherein the said substance is an extract of common yarrow plant ( Achillea millefolium), to prevent or fight against the effects of stress inducing the variations observed during the process of cutaneous aging, and/or to prevent and/or fight against the diminishing of epidermal homeostasis as part of the general context of aging, and/ or to improve cellular proliferation and differentiation, at the epidermal level, and/or to prevent and/or fight against the diminishing of epidermal thickness during chronobiological or photo-induced cutaneous aging or to generate a sensation of well-being, and wherein the skin cells are keratinocytes.
Method for producing and monitoring oral dissolvable films comprising a base whereto a solution comprising at least one active compound is applied, said method comprising the steps of • dosing and mixing the base formulation, • coating the base formulation onto a support to form a web, • optionally drying the support-coated base formulation web, • printing a dye solution comprising at least one active compound onto the upper side of the base formulation web by the flexographic printing process, • drying the support-coated base formulation web along with the printed active compound solution, • passing radiation from a radiation source from the upper and/or lower side through the support-coated base formulation web along with the printed active compound solution, • measuring the transmission of the transmitted radiation using at least one receiving unit on the opposite side of the support-coated base formulation web along with the printed active compound solution. • dosing and mixing the base formulation, • coating the base formulation onto a support to form a web, • optionally drying the support-coated base formulation web, • printing a dye solution comprising at least one active compound onto the upper side of the base formulation web by the flexographic printing process, • drying the support-coated base formulation web along with the printed active compound solution, • passing radiation from a radiation source from the upper and/or lower side through the support-coated base formulation web along with the printed active compound solution, • measuring the transmission of the transmitted radiation using at least one receiving unit on the opposite side of the support-coated base formulation web along with the printed active compound solution.
A method of classifying breast cancer, comprising: measuring the level of estrogen receptor, ER, expressed in cancerous breast tissue obtained from a patient, measuring the level of androgen receptor, AR, expressed in the cancerous breast tissue obtained from the patient, measuring the level of vitamin D receptor, VDR, expressed in the cancerous breast tissue obtained from the patient, classifying, in a first category HR0, a breast cancer tumor defined by a substantial lack of ER, AR, and VDR expression in the breast cancer tumor; classifying, in a second category HR1, a breast cancer tumor defined by expression of only one of ER, AR, and VDR in the breast cancer tumor; classifying, in a third category HR2, a breast cancer tumor defined by expression of any combination of two of ER, AR, and VDR in a breast cancer tumor; and classifying, in a fourth category HR3, a breast cancer tumor defined by expression of each of ER, AR, and VDR in the breast cancer tumor, and classifying the breast cancer tumor of the patient as HR0, HR1, HR2, or HR3 based on the expression levels of ER, AR, and VDR measured in the cancerous breast tissue, wherein tumors of said first category HR0, said second category HR1, said third category HR2, and said fourth category HR3 correspond to significant survival differences in patients. measuring the level of estrogen receptor, ER, expressed in cancerous breast tissue obtained from a patient, measuring the level of androgen receptor, AR, expressed in the cancerous breast tissue obtained from the patient, measuring the level of vitamin D receptor, VDR, expressed in the cancerous breast tissue obtained from the patient, classifying, in a first category HR0, a breast cancer tumor defined by a substantial lack of ER, AR, and VDR expression in the breast cancer tumor; classifying, in a second category HR1, a breast cancer tumor defined by expression of only one of ER, AR, and VDR in the breast cancer tumor; classifying, in a third category HR2, a breast cancer tumor defined by expression of any combination of two of ER, AR, and VDR in a breast cancer tumor; and classifying, in a fourth category HR3, a breast cancer tumor defined by expression of each of ER, AR, and VDR in the breast cancer tumor, and classifying the breast cancer tumor of the patient as HR0, HR1, HR2, or HR3 based on the expression levels of ER, AR, and VDR measured in the cancerous breast tissue, wherein tumors of said first category HR0, said second category HR1, said third category HR2, and said fourth category HR3 correspond to significant survival differences in patients.
A compound having one of the following structures: Cmpd. No. Structure 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392
A chemical-mechanical polishing composition comprising: (a) wet-process ceria, (b) a water-soluble cationic polymer or copolymer, wherein the water soluble cationic polymer is a cross linked cationic copolymer prepared from the polymerization of melamine or a halogenated derivative thereof and an aldehyde, (c) an aromatic carboxylic acid or heteroaromatic carboxylic acid, and (d) water, wherein the polishing composition has a pH of 3 to 6. (a) wet-process ceria, (b) a water-soluble cationic polymer or copolymer, wherein the water soluble cationic polymer is a cross linked cationic copolymer prepared from the polymerization of melamine or a halogenated derivative thereof and an aldehyde, (c) an aromatic carboxylic acid or heteroaromatic carboxylic acid, and (d) water,
Aircraft air conditioning system comprising: - an ambient air supply line allowing a flow of ambient air therethrough, - an ambient air cooling device connected to the ambient air supply line and being adapted to cool the ambient air flowing through the ambient air supply line, - an ambient air discharge line connected to the ambient air cooling device and being connectable to an aircraft cabin, - a compressed bleed air supply line allowing a flow of compressed air therethrough, - a compressed air cooling device connected to the compressed bleed air supply line and being adapted to cool the compressed air flowing through the compressed bleed air supply line, - a compressed air discharge line connected to the compressed air cooling device and being connectable to the aircraft cabin, and - a refrigerating apparatus which comprises a refrigerant circuit allowing the flow of a two-phase refrigerant therethrough and which is designed to convert the two-phase refrigerant, upon flowing though the refrigerant circuit, from the liquid state of aggregation into the gaseous state of aggregation and thereafter again back from the gaseous state of aggregation into the liquid state of aggregation, the refrigerant circuit of the refrigerating apparatus being adapted to supply cooling energy to the ambient air cooling device and the compressed air cooling device. - an ambient air supply line allowing a flow of ambient air therethrough, - an ambient air cooling device connected to the ambient air supply line and being adapted to cool the ambient air flowing through the ambient air supply line, - an ambient air discharge line connected to the ambient air cooling device and being connectable to an aircraft cabin, - a compressed bleed air supply line allowing a flow of compressed air therethrough, - a compressed air cooling device connected to the compressed bleed air supply line and being adapted to cool the compressed air flowing through the compressed bleed air supply line, - a compressed air discharge line connected to the compressed air cooling device and being connectable to the aircraft cabin, and - a refrigerating apparatus which comprises a refrigerant circuit allowing the flow of a two-phase refrigerant therethrough and which is designed to convert the two-phase refrigerant, upon flowing though the refrigerant circuit, from the liquid state of aggregation into the gaseous state of aggregation and thereafter again back from the gaseous state of aggregation into the liquid state of aggregation, the refrigerant circuit of the refrigerating apparatus being adapted to supply cooling energy to the ambient air cooling device and the compressed air cooling device.
A polymeric composition resulting from blending at least: i) about 94 weight percent to about 98.9 weight percent of a polycarbonate, based on the total weight of the polymeric composition, wherein the polycarbonate has a weight average molecular weight from 25,000 atomic mass units to about 40,000 atomic mass units, as measured using size exclusion chromatography according to the method disclosed in the specification; ii) about 0.050 percent by weight to about 0.120 percent by weight of one or more charring salt flame retardants, based on the total weight of the composition, wherein the one or more charring salt flame retardants includes at least 75 weight percent potassium perfluorobutane sulphonate, based on the total weight of the one or more charring salt flame retardant in the polymeric composition; and iii) about 1.1 weight percent to about 1.9 weight percent of a low molecular weight silicone compound having a degree of polymerization from 3 to 10, from 30 weight percent to 70 weight percent phenyl groups based on the total weight of the low molecular weight silicone compound, and 0.10 to 1.0 moles Si-H groups per 100 grams of the low molecular weight silicone compound; wherein the total weight of the polycarbonate, the charring salt flame retardant, and the low molecular weight silicone compound is from about 99.5 weight percent to about 100 weight percent, based on the total weight of the polymeric composition; wherein the polymeric composition has flame retardant characteristics so that it passes UL-94 V-O at 1.0 mm, UL-94 5VB at 2.5 mm, and UL-94 5VA at 2.5 mm. i) about 94 weight percent to about 98.9 weight percent of a polycarbonate, based on the total weight of the polymeric composition, wherein the polycarbonate has a weight average molecular weight from 25,000 atomic mass units to about 40,000 atomic mass units, as measured using size exclusion chromatography according to the method disclosed in the specification; ii) about 0.050 percent by weight to about 0.120 percent by weight of one or more charring salt flame retardants, based on the total weight of the composition, wherein the one or more charring salt flame retardants includes at least 75 weight percent potassium perfluorobutane sulphonate, based on the total weight of the one or more charring salt flame retardant in the polymeric composition; and iii) about 1.1 weight percent to about 1.9 weight percent of a low molecular weight silicone compound having a degree of polymerization from 3 to 10, from 30 weight percent to 70 weight percent phenyl groups based on the total weight of the low molecular weight silicone compound, and 0.10 to 1.0 moles Si-H groups per 100 grams of the low molecular weight silicone compound;
Kitchen appliance having a main body, in which an electric motor for driving the kitchen appliance is arranged, and a set-down region for setting down on a work surface, wherein the set-down region of the main body has set-down means moulded on in a 2C injection moulding procedure, characterised in that the set-down region has concentrically arranged ventilation slots, along which at least partially the set-down means are moulded on in an elongated manner, wherein the moulded-on set-down means have a circumferential linear contour, in order to provide a fluidic separation of the air inlets from the air outlets (13, 14).
A method for a User Equipment, in the following also referred to as UE, configured with at least two serving cells, including a Primary Cell, in the following also referred to as PCell, which is activated and an Secondary Cell, in the following also referred to as SCell, which is deactivated, comprising: receiving an SCell activation/deactivation Medium Access Control, in the following also referred to as MAC, control element to activate the SCell; activating the SCell based on the SCell activation/deactivation MAC control element; receiving a beam indication by a MAC control element via the PCell, wherein the beam indication includes a cell index and the beam indication is used to derive at least one beam to be used in the SCell; and using the at least one beam for a Downlink, in the following also referred to as DL, transmission or an Uplink, in the following also referred to as UL, transmission in the SCell. receiving an SCell activation/deactivation Medium Access Control, in the following also referred to as MAC, control element to activate the SCell; activating the SCell based on the SCell activation/deactivation MAC control element; receiving a beam indication by a MAC control element via the PCell, wherein the beam indication includes a cell index and the beam indication is used to derive at least one beam to be used in the SCell; and using the at least one beam for a Downlink, in the following also referred to as DL, transmission or an Uplink, in the following also referred to as UL, transmission in the SCell.
A Service Capability Server, SCS, in a mobile communication system for a device trigger, said SCS comprising: a controller configured to perform mutual authentication with a Machine Type Communication-Inter Working Function, MTC-IWF,; a transmitter configured to send an MTC device trigger message including trigger type information indicating availability of plural different device triggers to said MTC-IWF, to allow said MTC-IWF to check whether said SCS is authorized to send given type of trigger to an MTC device; and a receiver configured to receive a response from said MTC-IWF after said MTC device trigger message was sent to said MTC device, by the MTC-IWF, if the check by the MTC-IWF is passed. a controller configured to perform mutual authentication with a Machine Type Communication-Inter Working Function, MTC-IWF,; a transmitter configured to send an MTC device trigger message including trigger type information indicating availability of plural different device triggers to said MTC-IWF, to allow said MTC-IWF to check whether said SCS is authorized to send given type of trigger to an MTC device; and a receiver configured to receive a response from said MTC-IWF after said MTC device trigger message was sent to said MTC device, by the MTC-IWF, if the check by the MTC-IWF is passed.
A method of isolating an antibody in a composition containing an impurity, the method comprising: (a) adding a polyalkylene glycol to the composition; (b) adding a transition metal to the composition; (c) allowing said antibody to form a precipitate in the presence of said polyalkylene glycol and transition metal; and (d) separating said precipitated antibody from said impurity, wherein step (a) and step (b) can be carried out in any order. (a) adding a polyalkylene glycol to the composition; (b) adding a transition metal to the composition; (c) allowing said antibody to form a precipitate in the presence of said polyalkylene glycol and transition metal; and (d) separating said precipitated antibody from said impurity,
A polymerizable composition comprising a first monomer containing two functional groups derived from phthalonitrile and a second monomer containing three or more functional groups derived from phthalonitrile; wherein the first monomer is a compound of Formula 1 below: wherein, Ar 1 and Ar 2 are each independently an aromatic divalent radical, L, L 1 and L 2 are each independently a single bond, an alkylene group, an alkylidene group, an oxygen atom or a sulfur atom, and R 1 to R 10 are each independently hydrogen, an alkyl group, an alkoxy group, an aryl group or a cyano group, provided that at least two of R 1 to R 5 are each a cyano group and at least two of R 6 to R 10 are each a cyano group; and the second monomer is a compound of Formula 3, Formula 3: Ar 3 -L 3 -Ar 4 -L 4 -Ar 5 -L 5 -Ar 6 wherein, Ar 3 and Ar 6 are the same or different aryl groups from each other, Ar 4 and Ar 5 are the same or different arylene groups from each other, L 3 to L 5 are each independently an alkylene group, an alkylidene group, an alkenylene group or an alkynylene group, where Ar 3 to Ar 6 are each substituted with at least one substituent represented by Formula 4, wherein, L 6 is an alkylene group, an alkylidene group, an oxygen atom or a sulfur atom, and R 17 to R 21 are each independently hydrogen, an alkyl group, an alkoxy group, an aryl group or a cyano group, provided that at least two of R 17 to R 21 are each a cyano group. the second monomer is a compound of Formula 3, Formula 3: Ar 3 -L 3 -Ar 4 -L 4 -Ar 5 -L 5 -Ar 6 wherein, Ar 3 and Ar 6 are the same or different aryl groups from each other, Ar 4 and Ar 5 are the same or different arylene groups from each other, L 3 to L 5 are each independently an alkylene group, an alkylidene group, an alkenylene group or an alkynylene group, where Ar 3 to Ar 6 are each substituted with at least one substituent represented by Formula 4, wherein, L 6 is an alkylene group, an alkylidene group, an oxygen atom or a sulfur atom, and R 17 to R 21 are each independently hydrogen, an alkyl group, an alkoxy group, an aryl group or a cyano group, provided that at least two of R 17 to R 21 are each a cyano group.